DeepMed Research

Nanjing Medical University First Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Relationship Between Perioperative Carotid Blood Flow Monitoring and Cerebral Function Protection in Cardiac Surgery

Not Applicable

Completed

Conditions: Coronary Artery Bypass Grafting
Cardiopulmonary Bypass

Interventions: Other: normal saline
Drug: Nicardipine

First Posted Date: 2022-10-19

Last Posted Date: 2022-10-19

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 64

Registration Number: NCT05586347

Locations: 🇨🇳
Hongwei Shi, Nanjing, Jiangsu, China

Wound Bed Preparation for Diabetic Foot Ulcers

Not Applicable

Recruiting

Conditions: Diabetic Foot

Interventions: Procedure: Negative pressure wound therapy (NPWT)
Procedure: conventional moist dressings

First Posted Date: 2022-10-13

Last Posted Date: 2022-10-13

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 40

Registration Number: NCT05577104

Locations: 🇨🇳
Nanjing First Hospital, Nanjing, Jiangsu, China

The Exploreration of the Management for the Positive IAA in Patients With Type 2 Diabetes After Premix Insulin Therapy

Not Applicable

Recruiting

Conditions: Type 2 Diabetes Mellitus

Interventions: Other: Add GLP-1 receptor agonist
Other: Change insulin
Other: Add oral hyppoglycemia drug

First Posted Date: 2022-10-13

Last Posted Date: 2022-10-13

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 20

Registration Number: NCT05578352

Locations: 🇨🇳
Nanjing First Hospital, Nanjing Medical Univesity, Nanjing, China

The Comparison of Thick Split-thickness Skin Graft Versus Thin Split-thickness Skin Graft

Not Applicable

Recruiting

Conditions: Reconstruction

Interventions: Procedure: thick STSG; thin STSG

First Posted Date: 2022-10-07

Last Posted Date: 2022-10-13

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 40

Registration Number: NCT05571904

Locations: 🇨🇳
Nanjing First Hospital, Nanjing, Jiangsu, China

Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes

Phase 4

Recruiting

Conditions: Type 2 Diabetes Mellitus

Interventions: Drug: Tirzepatide
Drug: Insulin Glargine

First Posted Date: 2022-09-23

Last Posted Date: 2022-09-23

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 150

Registration Number: NCT05553093

Locations: 🇨🇳
Nanjing First Hospital, Nanjing, Jiangsu, China

Efficacy and Safety of Dual Therapy for Helicobacter Pylori Eradication

Phase 4

Completed

Conditions: Helicobacter Pylori Infection

Interventions: Drug: Vonoprazan
Drug: Amoxicillin

First Posted Date: 2022-07-22

Last Posted Date: 2024-06-13

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 914

Registration Number: NCT05469685

Locations: 🇨🇳
Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
🇨🇳
Changshu No.1 People's Hospital, Suzhou, Jiangsu, China
🇨🇳
Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China

and more 7 locations

Compare Continuous Gastrocnemius Plane Block With Intravenous Analgesia After Foot and Ankle Surgery

Phase 3

Conditions: Foot Ankle Injuries

Interventions: Drug: Continuous Gastrocnemius plane block with ropivacaine
Drug: oxycodone

First Posted Date: 2022-07-19

Last Posted Date: 2022-07-19

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 60

Registration Number: NCT05463809

Fucoidan Assisted Eradication of Helicobacter Pylori

Phase 1

Recruiting

Conditions: Helicobacter Pylori Infection
Intestinal Bacteria Flora Disturbance

Interventions: Other: Amoxicillin combined with vonoprazan
Biological: Amoxicillin combined with vonoprazan and fucoidan

First Posted Date: 2022-07-18

Last Posted Date: 2023-12-07

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 60

Registration Number: NCT05461508

Locations: 🇨🇳
Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China

PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI

Not Applicable

Recruiting

Conditions: Acute Coronary Syndrome
Hyperlipidemias
Percutaneous Coronary Intervention
Cardiovascular Events

Interventions: Drug: Placebo plus high-intensity statin
Drug: PCSK 9 Inhibitor plus high-intensity statin

First Posted Date: 2022-07-14

Last Posted Date: 2024-04-09

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 1212

Registration Number: NCT05457582

Locations: 🇨🇳
Nanjing First Hospital, Nanjing, Jiangsu, China

TAVR for Aortic Valve Disease

Recruiting

Conditions: Aortic Valve Disease

Interventions: Device: transcatheter heart valve

First Posted Date: 2022-06-30

Last Posted Date: 2024-11-15

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 5000

Registration Number: NCT05439863

Locations: 🇨🇳
Nanjing First Hospital, Nanjing, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy